Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6 - Wikidata - awgldk - TriplyDB

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

http://www.wikidata.org/entity/Q56771952

about

Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications Hypersensitivity Responses in the Central Nervous System Challenges and opportunities in designing clinical trials for neuromyelitis optica Molecular pathogenesis of neuromyelitis optica Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.Interferon-β exacerbates Th17-mediated inflammatory disease.Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.CD19 as a molecular target in CNS autoimmunity.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica Myasthenia Gravis during the Course of Neuromyelitis Optica.B lymphocytes in neuromyelitis optica Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes.Cytokine Therapies in Neurological Disease.Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats

P2860

Q21146701-EB411528-8454-4B6B-929F-A3C20BF9AFDF Q21558554-B0D45D84-234F-4A11-8846-7A150B998516 Q26767391-6DCF4522-4E56-4DAE-BBE7-9C5BFEF38806 Q26768649-E0110361-6EA8-4FEC-9158-00670FD85CCE Q26779177-6358A09E-E117-40A1-B2A8-8D15E6ACD1B7 Q26999708-6D1599EE-295D-4AAD-9720-21A8BAF42A37 Q27021535-639B19B3-B245-4FB4-A304-2577A56BBFC7 Q30676331-EDFDFC50-9733-4787-BA07-6460E08AC302 Q30833332-C7857D2B-36C1-4985-8DE9-5DC43423A516 Q33737913-5366D6F3-7597-4F14-B7F5-15E0077A06EC Q33758016-EBE76B1B-065D-494A-B6C4-B57F876D163C Q33770508-08171679-0829-4C3A-930C-DC959964FAD2 Q33808279-3988BA06-0085-46AB-BF0F-839EB0076B42 Q34166367-58676659-1FF0-4F9C-BD58-222E106B7C81 Q34181184-2F2727F6-8F7D-4AA8-92DC-ECCC319AFA3D Q34235490-2CE515C8-12DC-4C5E-91EB-2C3F67DABCA5 Q34392387-95116A5B-19A6-4571-8476-76611361EDD4 Q34700673-0C080F73-0F43-4663-A7B4-07AE12D2DFB3 Q34976749-764FE229-D187-4604-8F5E-9A42154B4165 Q35052199-2B06E16F-E8F1-442F-92A6-6ADF002FD7AB Q35067939-AFA32C26-0F3E-4CDE-A7D9-B5C8066816C5 Q35219651-D5285A09-3E55-4934-8612-01D2A9CC56E2 Q35574206-D669B5C7-0710-463A-8C10-8200CADA4290 Q35591039-DC9B1EF0-B196-4E1E-A467-019BC3FEE712 Q35870397-FDAECB81-50D2-431E-AAA7-F347404705A3 Q35871686-150D5FAE-0C7B-48DC-A066-508B3BB913DF Q35937581-8B4AF485-D9DA-4AB2-8CBE-6D03C641A08B Q35962565-19C4F1FB-F044-4BD8-AED8-BED2A65261C4 Q35993007-8B01F631-5DC1-44FE-A8D3-44BE002961F7 Q36110806-B7D85220-8ED6-44AD-BACB-FD296DB4769D Q36117107-B44750B1-B9DB-4684-ABAF-92A69A765BDF Q36310557-FF31E4C2-9C82-4E29-BBF1-9545E1C0CBEB Q36348690-60EF67A8-DCD4-4FD3-8D87-B461EE155F72 Q36484394-DFEC131A-DF34-4283-86A2-66D568C03C7F Q36547012-B6D3E172-7B85-4AD7-9B22-BBA75F67FF22 Q36814107-D290019A-69BC-4DDB-A3D6-313A673ED77B Q37053851-493407D2-459A-45F0-BCA2-7CA34F0BAA87 Q37084919-E2E8DAFB-F55A-4753-BAC9-627620055025 Q37136498-1426B8A6-6C2C-4827-82D8-D34F755E25BC Q37180238-A86353BD-7DB9-449A-BB16-C46B7DBB33D0

P2860

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

http://www.wikidata.org/entity/Q56771952

description

im August 2010 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2010

@uk

name

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

@en

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

@nl

type

label

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

@en

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

@nl

prefLabel

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

@en

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

@nl

P1433

Q56771952-B4FA7BA9-9CCE-489E-AE66-FE4D8B66FC6A

P1476

Q56771952-E6459FDF-D790-4614-AE40-E13E526F1B1F

P2093

Q56771952-2D82A296-AD51-4152-BC46-6214A518A373

Q56771952-2FFE0C0B-1DFB-4B45-89B2-912FEA078DCA

Q56771952-6C29658B-6583-4C22-AC56-C63B4D149CDA

Q56771952-7A1631DC-AE82-44E5-85D6-B98CB4141327

Q56771952-BAD92FAB-A25A-4058-8B36-61DB41A3070C

Q56771952-D9BB8F34-2092-465E-847B-96FB6B2A1FE1

Q56771952-F3939B0B-E5D8-4D31-915C-3723FE06B7C8

P2860

Q56771952-005D5407-F61C-444E-AD1B-17C36BA42C4E

Q56771952-0354E495-09D2-45EF-B86D-F611EFF74242

Q56771952-03FB91F7-1594-46FF-93DB-45F199FB193D

Q56771952-14AEDDF2-CEFF-495D-B4E8-436E46598091

Q56771952-1FF4993C-8697-4665-9539-879D8191575D

Q56771952-224DB54D-4ECF-4673-AD66-EB0707B4A910

Q56771952-2F4B7890-FC72-487B-8ABB-14AC67A92114

Q56771952-37C02D0C-54F8-43D5-A229-BCD1D6FB4743

Q56771952-409686FE-1792-42DC-BBF6-787FDCD969F3

Q56771952-47A6A356-67B3-4987-8670-A610D1E5CBAF

P304

Q56771952-73129D2A-1A69-4BC5-B9AF-3EA247DAD424

P31

Q56771952-B6609A7D-EF30-4A2F-859C-24F654087399

P356

Q56771952-9B07D0E1-D0DA-4865-8236-C2A1110FEDE3

P433

Q56771952-A29C346F-DD70-4834-9D75-509FD4641305

P478

Q56771952-4EB85BB6-BD18-4194-BDED-9938B93BE95C

P50

Q56771952-654C5D31-70CA-44A2-B039-7FFA75D8C248

P577

Q56771952-784195E3-E0EF-4515-9A78-1CA229F7869B

P698

Q56771952-CB114337-F98D-47C0-9CCE-3732121EA9AD

P921

Q56771952-16ea48d7-dc1c-41c8-8d52-4456cf96f533

P356

1352458510379247

P1433

Multiple Sclerosis Journal

P1476

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

@en

P2093

Akiyuki Uzawa

http://www.w3.org/2001/XMLSchema#string

Junko Taniguchi

http://www.w3.org/2001/XMLSchema#string

Kimihito Arai

http://www.w3.org/2001/XMLSchema#string

Masahiro Mori

http://www.w3.org/2001/XMLSchema#string

Saeko Masuda

http://www.w3.org/2001/XMLSchema#string

Sei Hayakawa

http://www.w3.org/2001/XMLSchema#string

Yasunori Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

Chemokines--chemotactic cytokines that mediate inflammation

IL-17 family cytokines and the expanding diversity of effector T cell lineages

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

The clinical course of neuromyelitis optica (Devic's syndrome).

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

The spectrum of neuromyelitis optica.

Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.

P304

1443-1452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458510379247

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Satoshi Kuwabara

P577

2010-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20739337

http://www.w3.org/2001/XMLSchema#string

P921